Zhu et al. reported that miR-448 inhibits tumorigenic processes such as growth, viability, migration, and invasion of hepatocellular carcinoma cell lines through targeting ROCK2 [24]. The gene discussed is ROCK2; the disease is hepatocellular carcinoma.